Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine

Historical observation

20182026

Universe›Health Care›Pharmaceuticals›Pharmaceuticals

1 · Sector

Weight and 12M allocation change

Materials29.6%+26.14 pp Consumer Discretionary8.5%+1.82 pp Real Estate2.1%-1.21 pp Utilities2.3%-1.33 pp Energy2.3%-1.64 pp Communication Services2.1%-1.72 pp Consumer Staples5.3%-2.38 pp Industrials6.9%-3.12 pp Financials7.8%-5.05 pp Health Care11.8%-5.74 pp Information Technology21.2%-5.77 pp

2 · Industry

Inside Health Care

Pharmaceuticals3.77%-1.83 pp Managed Health Care1.62%-0.88 pp Health Care Equipment2.30%-0.81 pp Biotechnology1.77%-0.80 pp Life Sciences Tools & Services1.27%-0.79 pp Health Care Services0.49%-0.43 pp Health Care Distributors0.29%-0.09 pp Health Care Supplies0.13%-0.05 pp Health Care Facilities0.18%-0.04 pp Health Care Technology0.00%+0.00 pp

3 · Sub-industry

Inside Pharmaceuticals

Pharmaceuticals3.77%-1.833 pp

Concentrated

Most of this industry's losses came from a few companies.

View all contributions →

Pharmaceuticals · weight

3.77%

Industry change · 12M

-1.83 pp

Pharmaceuticals · contribution

-1.833 pp

Company participation

of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

May 2023 · sorted by absolute contribution to 12-month change

Company	Country	Market cap	Universe weight	3M contribution	12M contribution	12M price return	Above 6M weight average
Johnson & Johnson → JNJ	United States	$403.0bn	0.995%	-0.408 pp	-0.706 pp	-11.2%	No
Pfizer → PFE	United States	$214.6bn	0.530%	-0.271 pp	-0.542 pp	-25.7%	No
Bristol Myers Squibb → BMY	United States	$135.4bn	0.334%	-0.174 pp	-0.244 pp	-11.9%	No
Merck & Co. → MRK	United States	$280.2bn	0.692%	-0.256 pp	-0.146 pp	+23.6%	No
Zoetis → ZTS	United States	$75.3bn	0.186%	-0.086 pp	-0.104 pp	-3.8%	No
Lilly (Eli) → LLY	United States	$407.7bn	1.007%	-0.033 pp	-0.065 pp	+38.7%	No
Viatris → VTRS	United States	$11.0bn	0.027%	-0.021 pp	-0.026 pp	-21.9%	No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.